DPYSL2 and diabetes mellitus: Accordingly, CRMP2 levels are promoted among the cells with higher proliferation potential in mice receiving AOM/DSS treatment, and diabetic hyperglycemia is suggested to accelerate CRC pathogenesis in CRC-DM.